BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33378977)

  • 1. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model.
    Fan Y; Hao Y; Gao D; Li G; Zhang Z
    Physiol Res; 2021 Apr; 70(2):213-226. PubMed ID: 33676385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 4. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1 promotes the development of pulmonary arterial hypertension in rats.
    Sadamura-Takenaka Y; Ito T; Noma S; Oyama Y; Yamada S; Kawahara K; Inoue H; Maruyama I
    PLoS One; 2014; 9(7):e102482. PubMed ID: 25032709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity.
    Zimmer A; Teixeira RB; Constantin RL; Campos-Carraro C; Aparicio Cordero EA; Ortiz VD; Donatti L; Gonzalez E; Bahr AC; Visioli F; Baldo G; Luz de Castro A; Araujo AS; Belló-Klein A
    Eur J Pharmacol; 2021 Jan; 891():173699. PubMed ID: 33160936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Beet Juice Supplementation on Monocrotaline-Induced Pulmonary Hypertension in Rats.
    Tawa M; Yano Y; Yamanaka M; Sawano T; Iesaki K; Murata Y; Tanaka R; Nakagawa K; Ohkita M; Matsumura Y
    Am J Hypertens; 2019 Jan; 32(2):216-222. PubMed ID: 30265283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate Oligosaccharide Alleviates Monocrotaline-Induced Pulmonary Hypertension via Anti-Oxidant and Anti-Inflammation Pathways in Rats.
    Feng W; Hu Y; An N; Feng Z; Liu J; Mou J; Hu T; Guan H; Zhang D; Mao Y
    Int Heart J; 2020 Jan; 61(1):160-168. PubMed ID: 31956132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
    Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway.
    Yin Q; Wang S; Yang J; Fan C; Yu Y; Li J; Mei F; Zhang S; Xi R; Zhang X
    J Pharm Pharmacol; 2023 Aug; 75(8):1100-1110. PubMed ID: 37158759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
    Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of masitinib compared with tadalafil for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.
    Leong ZP; Hikasa Y
    Vascul Pharmacol; 2019; 122-123():106599. PubMed ID: 31629919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.